07:05 EST GH Research (GHRS) to seek FDA alignment on Phase 3 program replicating Phase 2b design
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GHRS:
- GH Research says FDA lifts clinical hold on GH001
- GH Research: Phase 3 initiation targeted for 2026
- GH Research Sets January 5 Update on IND Status and Phase 3 Plans for Lead TRD Drug GH001
- GH Research to Present Promising Results on GH001 at ACNP 2026
- GH Research PLC Reports Q3 2025 Financial Results